NICE widens somatropin recommendations for children
This article was originally published in Scrip
NICE, the National Institute for health and Clinical Excellence, has recommended two new indications for the recombinant human growth hormone somatropin when used to treat growth failure in children on the NHS in England and Wales.
You may also be interested in...
UK HTA body NICE is looking to the future and rethinking its approach to data and how they inform its guidance.
Performance-based managed entry agreements need to be made more effective, but this can only happen if countries relax their stance on confidentiality and share information on MEAs amongst themselves, says a working paper from the OECD.
The Netherlands will secure lower medicine prices by referencing Norway instead of Germany to set maximum prices.